TY - JOUR
T1 - NCKAP1 Disruptive Variants Lead to a Neurodevelopmental Disorder with Core Features of Autism
AU - Guo, Hui
AU - Zhang, Qiumeng
AU - Dai, Rujia
AU - Yu, Bin
AU - Hoekzema, Kendra
AU - Tan, Jieqiong
AU - Tan, Senwei
AU - Jia, Xiangbin
AU - Chung, Wendy K.
AU - Hernan, Rebecca
AU - Alkuraya, Fowzan S.
AU - Alsulaiman, Ahood
AU - Al-Muhaizea, Mohammad A.
AU - Lesca, Gaetan
AU - Pons, Linda
AU - Labalme, Audrey
AU - Laux, Linda
AU - Bryant, Emily
AU - Brown, Natasha J.
AU - Savva, Elena
AU - Ayres, Samantha
AU - Eratne, Dhamidhu
AU - Peeters, Hilde
AU - Bilan, Frédéric
AU - Letienne-Cejudo, Lucile
AU - Gilbert-Dussardier, Brigitte
AU - Ruiz-Arana, Inge Lore
AU - Merlini, Jenny Meylan
AU - Boizot, Alexia
AU - Bartoloni, Lucia
AU - Santoni, Federico
AU - Karlowicz, Danielle
AU - McDonald, Marie
AU - Wu, Huidan
AU - Hu, Zhengmao
AU - Chen, Guodong
AU - Ou, Jianjun
AU - Brasch-Andersen, Charlotte
AU - Fagerberg, Christina R.
AU - Dreyer, Inken
AU - chun-hui Tsai, Anne
AU - Slegesky, Valerie
AU - McGee, Rose B.
AU - Daniels, Brina
AU - Sellars, Elizabeth A.
AU - Carpenter, Lori A.
AU - Schaefer, Bradley
AU - Sacoto, Maria J.Guillen
AU - Begtrup, Amber
AU - Schnur, Rhonda E.
AU - Punj, Sumit
AU - Wentzensen, Ingrid M.
AU - Rhodes, Lindsay
AU - Pan, Qian
AU - Bernier, Raphael A.
AU - Chen, Chao
AU - Eichler, Evan E.
AU - Xia, Kun
N1 - Funding Information:
We are grateful to the families involved in this study. We thank Tonia Brown for assistance in editing this manuscript. We thank Mais Hashem, Egidio Spinelli, and John J. Millichap for coordinating data collection. This work was supported by the following grants: the National Natural Science Foundation of China ( 81871079 , 81330027 , 81525007 , 8173000779 , 81671122 ) to H.G., K.X., and Z.H.; The US National Institutes of Health (NIH) grant ( MH101221 ) to E.E.E.; and the Hunan Provincial grants ( 2018SK1030 , 2018DK2016 , 2019SK1015 , 2019RS2005 ) to K.X., Z.H., and H.G. H.G. was also supported by the Innovation-Driven Project of Central South University ( 2020CX042 ). N.J.B., E.S., S.A., and D.E. was supported by the State Government of Victoria (Department of Health and Human Services, Melbourne Genomics Health Alliance). J.M.M. and F.S. are supported by the Swiss National Science Foundation ( 310030_185292 ). W.K.C. is supported by grants from the Simons Foundation and the JPB Foundation. E.E.E. is an investigator of the Howard Hughes Medical Institute .
PY - 2020/11/5
Y1 - 2020/11/5
N2 - NCKAP1/NAP1 regulates neuronal cytoskeletal dynamics and is essential for neuronal differentiation in the developing brain. Deleterious variants in NCKAP1 have been identified in individuals with autism spectrum disorder (ASD) and intellectual disability; however, its clinical significance remains unclear. To determine its significance, we assemble genotype and phenotype data for 21 affected individuals from 20 unrelated families with predicted deleterious variants in NCKAP1. This includes 16 individuals with de novo (n = 8), transmitted (n = 6), or inheritance unknown (n = 2) truncating variants, two individuals with structural variants, and three with potentially disruptive de novo missense variants. We report a de novo and ultra-rare deleterious variant burden of NCKAP1 in individuals with neurodevelopmental disorders which needs further replication. ASD or autistic features, language and motor delay, and variable expression of intellectual or learning disability are common clinical features. Among inherited cases, there is evidence of deleterious variants segregating with neuropsychiatric disorders. Based on available human brain transcriptomic data, we show that NCKAP1 is broadly and highly expressed in both prenatal and postnatal periods and demostrate enriched expression in excitatory neurons and radial glias but depleted expression in inhibitory neurons. Mouse in utero electroporation experiments reveal that Nckap1 loss of function promotes neuronal migration during early cortical development. Combined, these data support a role for disruptive NCKAP1 variants in neurodevelopmental delay/autism, possibly by interfering with neuronal migration early in cortical development.
AB - NCKAP1/NAP1 regulates neuronal cytoskeletal dynamics and is essential for neuronal differentiation in the developing brain. Deleterious variants in NCKAP1 have been identified in individuals with autism spectrum disorder (ASD) and intellectual disability; however, its clinical significance remains unclear. To determine its significance, we assemble genotype and phenotype data for 21 affected individuals from 20 unrelated families with predicted deleterious variants in NCKAP1. This includes 16 individuals with de novo (n = 8), transmitted (n = 6), or inheritance unknown (n = 2) truncating variants, two individuals with structural variants, and three with potentially disruptive de novo missense variants. We report a de novo and ultra-rare deleterious variant burden of NCKAP1 in individuals with neurodevelopmental disorders which needs further replication. ASD or autistic features, language and motor delay, and variable expression of intellectual or learning disability are common clinical features. Among inherited cases, there is evidence of deleterious variants segregating with neuropsychiatric disorders. Based on available human brain transcriptomic data, we show that NCKAP1 is broadly and highly expressed in both prenatal and postnatal periods and demostrate enriched expression in excitatory neurons and radial glias but depleted expression in inhibitory neurons. Mouse in utero electroporation experiments reveal that Nckap1 loss of function promotes neuronal migration during early cortical development. Combined, these data support a role for disruptive NCKAP1 variants in neurodevelopmental delay/autism, possibly by interfering with neuronal migration early in cortical development.
KW - NCKAP1
KW - autism spectrum disorder
KW - de novo variants
KW - disruptive variant
KW - genotype-phenotype correlation
KW - neurodevelopmental disorder
UR - http://www.scopus.com/inward/record.url?scp=85094968926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85094968926&partnerID=8YFLogxK
U2 - 10.1016/j.ajhg.2020.10.002
DO - 10.1016/j.ajhg.2020.10.002
M3 - Article
C2 - 33157009
AN - SCOPUS:85094968926
VL - 107
SP - 963
EP - 976
JO - American Journal of Human Genetics
JF - American Journal of Human Genetics
SN - 0002-9297
IS - 5
ER -